Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females
DHS TanDivisions of Infectious Diseases, St Michael's Hospital, University Health Network, and University of Toronto, Toronto, CanadaAbstract: A surprising result of the groundbreaking CAPRISA-004 trial, which demonstrated the efficacy of vaginal tenofovir 1% gel in reducing the risk of huma...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2012-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|